Andrew Alexander McCall

Andrew McCall practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Andrew McCall's NPI, 1043487531, was assigned on May 13, 2008. Andrew McCall graduated from David Geffen School of Medicine at UCLA in 2002. Andrew McCall holds California license A87517.

Andrew McCall's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Andrew McCall's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Andrew McCall is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is UCLA Head & Neck Associates. Dmand AI also links Andrew McCall to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Andrew McCall practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Andrew McCall's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Andrew McCall is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Andrew McCall's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists chronic ear infection, ear eustachian tube disorders, ear infection, hearing loss and impairment, swimmer's ear, tinnitus and vertigo among the conditions Andrew McCall treats.

CMS data shows 462 Medicare services from Andrew McCall across 6 procedure codes in 2024, for 234 Medicare patients. Medicare paid $23,619 for them. Every service was in an office.

CMS counts 234 Medicare patients who saw Andrew McCall in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high cholesterol, and 61% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Andrew McCall's median patient age at 60, with 52% women.

In 2024, Andrew McCall wrote 159 Medicare Part D claims for 86 patients. 90% of them were for generic drugs. CMS names the drug for 79 of them, across 3 drugs with 11 or more claims each, at $6,626 in total drug cost. In 2023, CMS named 73 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Andrew McCall for performance year 2024, reported as part of a group. Andrew McCall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Andrew McCall as offering telehealth.

Dmand AI links 56 papers to Andrew McCall, published from 2010 to 2025. 2013 was the busiest year, with 7. The most frequent topics are Cats, Vestibule, Labyrinth and Neurons. Andrew McCall has published most often in Otol Neurotol. Andrew McCall's most frequent co-authors are Candace E. Hobson, MD, Derek Wade Miller, DO and William Madison Demayo, MD.

CMS Open Payments shows 5 general payments to Andrew McCall from 4 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 90% of the total. iotaMotion, Inc. paid the most, $1,050.

Dmand AI lists 1 award for Andrew McCall, most recently CMS Stage 1 EHR in 2011.

Andrew McCall graduated from David Geffen School of Medicine at UCLA in 2002.

Andrew McCall is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.